| |
|
|
|
Fulgent Genetics Inc.  
|
|
4.3306 -0.069 (-0.02%) |
02-19 15:20 |
|
Open: |
4.32 |
Pre close: |
4.4 |
Target:
|
5.24
|
|
High: |
4.35 |
Low: |
4.3 |
Resistance:
|
4.49
5.24
|
|
Volume: |
2,739 |
Market Cap: |
78M |
Support:
|
3.77
 3.32
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.26
|
MACD |
MACD(12,26):
|
0.13 |
|
MA(20): |
4.08 |
Signal(12,26,9): |
0.11 |
|
MA(100): |
3.70 |
Stochastic Oscillator |
%K(14,3):
|
85.98  |
|
MA(250): |
3.94 |
%D(3): |
84.71 |
|
Average Volume(K) |
3-Month: |
1955
|
52-Week |
High:
|
5.56 |
|
10-Days: |
158 |
Low: |
3.02 |
|
RSI |
RSI(14):
|
58.58 |
Change(%): |
-3.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.240 |
Return on Equity (ttm) |
-9.6 |
Shares Out. (M) |
18.07 |
|
EPS Est. Current Year |
0.140 |
Return on Assets (ttm) |
-9.2 |
Shares Float (M) |
8.81 |
|
EPS Est. Next Year |
0.320 |
PEG Ratio |
-1.35 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.070 |
Qtrly Rev. Growth |
24.9 |
% Held by Institutions |
9.30 |
|
Forward EPS |
0.070 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
1.390 |
EBITDA (p.s.) |
0.000 |
P/E |
-17.92 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.09 |
|
Profit Margin |
-22.67 |
Operating Cash Flow
(M) |
-2.69 |
P/S |
69375896.00 |
|
Operating Margin |
-30.62 |
Levered Free Cash Flow
(M) |
-6.64 |
P/CF |
-28.88 |
|
|
|
|
|
|
